Isabella Del Priore

Title: Isabella Del Priore: Innovator in Pharmaceutical Research

Introduction

Isabella Del Priore is a notable inventor based in Smithtown, NY (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments for pulmonary arterial hypertension (PAH). Her work exemplifies the intersection of science and medicine, showcasing the importance of research in improving patient outcomes.

Latest Patents

Isabella holds 1 patent for her invention titled "Anti-PDGF-B antibodies and pharmaceutical composition thereof." This patent focuses on anti-Platelet-Derived Growth Factor Subunit B (PDGF-B) antibodies and their antigen-binding fragments. The methods described in her patent are aimed at treating subjects suffering from pulmonary arterial hypertension, highlighting her commitment to addressing critical health issues.

Career Highlights

Isabella is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her role at Regeneron allows her to collaborate with leading experts in the field, further enhancing her contributions to pharmaceutical innovation.

Collaborations

Some of her notable coworkers include Yinglin Gao and Scott Macdonnell. Their collaborative efforts contribute to the dynamic research environment at Regeneron, fostering innovation and the development of new therapeutic solutions.

Conclusion

Isabella Del Priore's work in developing anti-PDGF-B antibodies represents a significant advancement in the treatment of pulmonary arterial hypertension. Her dedication to research and collaboration with esteemed colleagues underscores her impact on the pharmaceutical industry.